Provided by Tiger Fintech (Singapore) Pte. Ltd.

Werewolf Therapeutics, Inc.

1.21
-0.0300-2.42%
Post-market: 1.210.00000.00%16:10 EDT
Volume:66.02K
Turnover:81.04K
Market Cap:54.30M
PE:-0.73
High:1.29
Open:1.23
Low:1.21
Close:1.24
Loading ...
Jun 25, 2024

Major Issues Report

Form 8-K - Current report
Jun 03, 2024

Major Issues Report

Form 8-K - Current report
May 28, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 03, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2024

Major Issues Report

Form 8-K - Current report
Mar 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 07, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Dec 21, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2023

Major Issues Report

Form 8-K - Current report